Free Trial

Cytokinetics (CYTK) SEC Filings & 10K Form

Cytokinetics logo
$38.68 +0.67 (+1.76%)
Closing price 04:00 PM Eastern
Extended Trading
$38.19 -0.49 (-1.27%)
As of 04:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cytokinetics SEC Filings

DateFilerForm TypeView
07/15/2025
4:38 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2025
3:21 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2025
3:22 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2025
3:27 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
4:19 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
3:21 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2025
5:51 PM
Bhanji Muna (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
5:46 PM
Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
6:23 PM
Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
6:25 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
6:27 PM
Cytokinetics (Issuer)
Landry Robert E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
6:35 PM
Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
6:40 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
6:42 PM
Bhanji Muna (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2025
9:37 AM
Cytokinetics (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
Form SCHEDULE 13G
05/06/2025
3:30 PM
Cytokinetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2025
3:37 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
5:21 PM
Callos Andrew (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
3:15 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2025
3:33 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
4:42 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
3:14 PM
Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2025
3:25 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
3:32 PM
Cytokinetics (Subject)
HENDERSON JOHN T (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2025
4:40 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2025
6:30 AM
Cytokinetics (Filer)
Form DEF 14A
04/10/2025
6:31 AM
Cytokinetics (Filer)
Form ARS
04/08/2025
5:02 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
4:03 PM
Callos Andrew (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
3:24 PM
Callos Andrew (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/31/2025
9:29 AM
Cytokinetics (Filer)
Form PRE 14A
03/19/2025
5:03 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
3:29 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
3:17 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
3:20 PM
Callos Andrew (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
3:08 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
7:19 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
7:21 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
7:23 PM
Callos Andrew (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
3:36 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
7:53 PM
Callos Andrew (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Bank of America Says Gold Could Hit $4,000. Here How to Get Paid (Ad)

“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist believed — until he found a little-known $15 gold ETF that’s now paying up to 64% annually in monthly cash. No mining stocks. No futures. Just steady income from an asset that used to pay nothing.

See the gold income fund paying 64% annually
03/14/2025
3:26 PM
Callos Andrew (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2025
3:32 PM
Callos Andrew (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2025
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
7:39 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:41 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:43 PM
Callos Andrew (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:43 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:06 PM
Cytokinetics (Subject)
Harrington Robert Arthur (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
4:24 PM
Cytokinetics (Filer)
Form S-3ASR
02/12/2025
8:28 AM
Cytokinetics (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
02/11/2025
7:26 AM
Cytokinetics (Issuer)
Landry Robert E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
7:18 AM
Cytokinetics (Issuer)
Landry Robert E (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/11/2025
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
3:31 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:25 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
10:29 AM
Cytokinetics (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/07/2025
3:17 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2025
3:22 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:23 PM
Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:25 PM
Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:25 PM
Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:27 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
6:23 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:38 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
3:13 PM
Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
9:17 AM
Cytokinetics (Subject)
HENDERSON JOHN T (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
4:42 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:30 PM
Cytokinetics (Issuer)
Lee Sung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:32 PM
Cytokinetics (Issuer)
Wong Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:22 PM
Callos Andrew (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:28 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
5:46 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:01 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
6:05 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
4:38 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:10 PM
Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
5:02 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
4:04 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
8:55 AM
Cytokinetics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
11/04/2024
4:45 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
10:17 AM
Cytokinetics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/01/2024
3:43 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
3:45 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2024
3:49 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:12 PM
Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
4:04 PM
BlackRock, Inc. (Filed by)
Cytokinetics (Subject)
Form SC 13G/A
10/16/2024
5:45 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:32 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/09/2024
3:08 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
4:24 PM
Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
[ATTENTION] This Crypto Rocket Is About Launch… (Ad)

Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to two crypto experts, that moment is here. Their Crypto Code Workshop shows how to get positioned before altcoins take off, ride the wave, and lock in gains — with a free $10 Bitcoin bonus just for attending.

Join The Crypto Code Workshop + get $10 in Bitcoin for attending
10/03/2024
4:25 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
4:26 PM
Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
4:27 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
4:28 PM
Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
3:48 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
5:56 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:15 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
3:29 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2024
4:06 PM
Cytokinetics (Issuer)
Pletcher Brett A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CYTK) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners